News In Brief

LIVE TALK sessions are now available on Demand.  Click here to listen to past shows.

From Recordati Rare Diseases Phase III study confirms the efficacy and safety of   ISTURISA®.  achieving sustained cortisol control in the majority of patients. Read more

Good news from Amryt Pharma for acromegaly patients in Europe.  Read the release from Amryt Pharma on Mycapssa® here.

Corcept Therapeutics announces new communication materials for Phase 3 Trial of Relacolirant in patients with Cushing’s syndrome.  Click here to learn more and see if you qualify. 

Crinetics Pharmaceuticals moves forward with Paltusotine® phase 3 study.  To learn more about the trial and see if you qualify Read more here

Read more about clinical trials from  Xeris Pharma, Camurus AB, and  Ionis Ph

The Podcast

Knowledge and information are critical tools to affect early diagnosis in pituitary disease. Join Dr. Lewis Blevins and Jorge D Faccinetti cofounders, as they navigate the wonders and complexities of pituitary conditions.

Our live talk session from May 12 is now available on-demand with guests Jill Sisco, president of the Acromegaly Community, and Sharmyn McGraw from the Pacific Neuroscience Institute.  This was a fascinating perspective on the challenges and opportunities for patient advocacy programs with two of the leading patient advocates in the world of pituitary disease, specifically Cushing's and acromegaly.  We talked about the voice of the patient initiatives, support groups, unmet needs, access to medication, and new initiatives to participate in making life better for people dealing with pituitary disease.  Don't miss it, and join us next Thursday for another Live Talk session!

A highly informational "live-talk" session from Dr. Blevins.  The first segment covers the indications for pituitary surgery for patients with pituitary adenomas.  In the second half of the program, he discusses critical information for patients with Central Adrenal Insufficiency due to hypothalamic or pituitary disease.